USANA HEALTH SCIENCES INC
For the period ended Dec 30, 2023. Filed Feb 27, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 27, 2024
USNA$13.85+1.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
(in thousands, except par value)
| As ofDecember 30,2023 | As ofDecember 31,2022 | |
|---|---|---|
| ASSETS | ||
| Current assets | ||
| Cash and cash equivalents | $330,420 | $288,420 |
| Inventories | 61,454 | 67,089 |
| Prepaid expenses and other current assets | 25,872 | 28,873 |
| Total current assets | 417,746 | 384,382 |
| Property and equipment, net | 99,814 | 97,773 |
| Goodwill | 17,102 | 17,368 |
| Intangible assets, net | 29,919 | 32,432 |
| Deferred tax assets | 13,284 | 9,799 |
| Other assets | 54,892 | 54,795 |
| $632,757 | $596,549 | |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| Current liabilities | ||
| Accounts payable | $10,070 | $11,049 |
| Line of credit - short term | 786 | — |
| Other current liabilities | 107,989 | 132,784 |
| Total current liabilities | 118,845 | 143,833 |
| Deferred tax liabilities | 4,552 | 4,071 |
| Other long-term liabilities | 12,158 | 14,173 |
| Stockholders' equity | ||
| Common stock, $0.001 par value; Authorized -- 50,000 shares, issued and outstanding 19,130 as of December 30, 2023 and 19,206 as of December 31, 2022 | 19 | 19 |
| Additional paid-in capital | 65,661 | 55,604 |
| Retained earnings | 445,217 | 391,636 |
| Accumulated other comprehensive income (loss) | (13,695) | (12,787) |
| Total stockholders' equity | 497,202 | 434,472 |
| $632,757 | $596,549 | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.